This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Viela Bio, Inc.. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Yan Chen - Innovator in Autoimmune Disease Treatment
Introduction
Yan Chen is a prominent inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. His work focuses on addressing autoimmune and inflammatory diseases, showcasing his commitment to advancing medical science.
Latest Patents
Yan Chen holds a patent for "Antibodies to Feline McDonough Sarcoma (FMS)-like tyrosine kinase 3 receptor ligand (FLT3L) and uses thereof for treating autoimmune and inflammatory diseases." This patent details the development of anti-FLT3L antibodies and outlines methods for utilizing these antibodies in the treatment of various autoimmune and inflammatory conditions. His innovative approach has the potential to improve treatment options for patients suffering from these diseases.
Career Highlights
Currently, Yan Chen is associated with Viela Bio, Inc., where he continues to work on groundbreaking research. His expertise in antibody development has positioned him as a key figure in the biotechnology sector. With a focus on therapeutic applications, he is dedicated to finding solutions that can significantly impact patient care.
Collaborations
Yan collaborates with esteemed colleagues, including Xiao Xiaodong and Catherine Ettinger. Their combined efforts contribute to the advancement of research and development in the field of autoimmune diseases.
Conclusion
In summary, Yan Chen is an influential inventor whose work in antibody development is paving the way for new treatments for autoimmune and inflammatory diseases. His contributions to biotechnology are noteworthy and reflect his dedication to improving healthcare outcomes.